Kestra Medical Technologies (KMTS) Non Operating Interest Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Non Operating Interest Expenses for 3 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 4.77% year-over-year to $1.8 million in Q2 2026; TTM through Apr 2026 was $7.5 million, a 2.44% decrease from a year earlier, with the FY2026 full-year figure at $7.5 million, down 2.43% from the prior year.
• Non Operating Interest Expenses was $1.8 million for Q2 2026 at Kestra Medical Technologies, down from $1.9 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $2.3 million in Q4 2024 and troughed at $1.7 million in Q1 2024.
• A 3-year average of $1.9 million and a median of $1.9 million in 2024 frame the typical range for Non Operating Interest Expenses.
• The widest YoY moves for Non Operating Interest Expenses: up 8.0% in 2025, down 17.95% in 2025.
• Over 3 years, Non Operating Interest Expenses stood at $2.3 million in 2024, then retreated by 17.95% to $1.9 million in 2025, then decreased by 3.0% to $1.8 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $1.8 million (Q2 2026), $1.9 million (Q1 2026), and $1.9 million (Q4 2025), per Business Quant data.